These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 15932162
1. [Pharmacoeconomic analysis (ABC, VEN and frequency analysis) of treatment of non-complicated duodenal ulcer associated with Helicobacter pylori in the specialized in-patient clinic]. Guseĭnzade MG. Eksp Klin Gastroenterol; 2005; (2):88-94. PubMed ID: 15932162 [No Abstract] [Full Text] [Related]
3. [Eradication of Helicobacter pylori]. Herszényi L. Orv Hetil; 2003 Oct 05; 144(40):1991-2. PubMed ID: 14626641 [No Abstract] [Full Text] [Related]
4. [Losek therapy of duodenal ulcer in contamination with different strains of Helicobacter pylori]. Isakov VA, Lapina TL, Ivanikov IO, Khomeriki NM, Kudriavtseva LV. Klin Med (Mosk); 1999 Oct 05; 77(11):44-6. PubMed ID: 10635634 [No Abstract] [Full Text] [Related]
5. [Should H. pylori infection in duodenal ulcer be confirmed before administering eradicating treatment?]. Gisbert JP, Pajares JM. Med Clin (Barc); 1999 Jul 03; 113(4):134-7. PubMed ID: 10472599 [No Abstract] [Full Text] [Related]
6. [Helicobacter pylori and gastroduodenal pathology in patient with chronic renal insufficiency undergoing dialysis]. Calvet X, Almirall J, López T. Nefrologia; 2002 Jul 03; 22(4):318-24. PubMed ID: 12369122 [No Abstract] [Full Text] [Related]
7. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori? Güliter S, Keleş H, Ozkurt ZN, Cengiz DU, Kolukisa E. Turk J Gastroenterol; 2005 Mar 03; 16(1):29-33. PubMed ID: 16252185 [Abstract] [Full Text] [Related]
8. [Clinical and pharmacoeconomic substantiation of the modification of eradication therapy regimens for Helicobacter pylori-associated diseases]. Grinevich VB, Samedov BKh, Uspenskiĭ IuP, Gubonina IV. Eksp Klin Gastroenterol; 2004 Mar 03; (2):16-21. PubMed ID: 15462313 [No Abstract] [Full Text] [Related]
9. [Impact of the anti-Helicobacter therapy on the life quality of patients with duodenal ulcers]. Guseĭnzade MG. Eksp Klin Gastroenterol; 2005 Mar 03; (5):22-7. PubMed ID: 16518910 [No Abstract] [Full Text] [Related]
10. [Pharmacoeconomic aspects of Helicobacter pylori-associated duodenal ulcer]. Lazebnik LB, Kas'ianenko VI. Eksp Klin Gastroenterol; 2004 Mar 03; (2):25-9. PubMed ID: 15462315 [No Abstract] [Full Text] [Related]
11. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer. Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EV. J Gastroenterol Hepatol; 2008 Nov 03; 23(11):1666-71. PubMed ID: 17559360 [Abstract] [Full Text] [Related]
12. [Effect of eradication therapy on nitrogen oxide activity in the gastric juice of patients with chronic gastritis and ulcer disease]. Esedov EM, Magomedéminova AS. Klin Med (Mosk); 2009 Nov 03; 87(7):50-2. PubMed ID: 19705793 [Abstract] [Full Text] [Related]
13. [Long- and short-term results of staged treatment of ulcer patients working in oil production industry]. Muravtseva OV, Vakhrushev IaM. Ter Arkh; 2009 Nov 03; 81(2):36-8. PubMed ID: 19334487 [Abstract] [Full Text] [Related]